Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Clicks: 536
ID: 112562
1993
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
72.7
/100
536 views
360 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #3 of 105 articles by views in Antimicrobial agents and chemotherapy
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Seventy-four acutely ill patients were treated with intravenous ciprofloxacin at dosages ranging between 200 mg every 12 h and 400 mg every 8 h. A population pharmacokinetic-pharmacodynamic analysis relating drug exposure (and other factors) to infectious outcome was performed. Plasma samples were o …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (39 words).
Try re-searching for a better abstract.
| Reference Key |
a1993antimicrobialpharmacodynamics
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Forrest A;Nix DE;Ballow CH;Goss TF;Birmingham MC;Schentag JJ;; |
| Journal | Antimicrobial agents and chemotherapy |
| Year | 1993 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
algorithms
adult
female
male
aged
middle aged
Drug Administration Schedule
Prospective Studies
80 and over
Clinical Trial
multivariate analysis
ciprofloxacin / therapeutic use
ciprofloxacin / pharmacology*
analysis of variance
ciprofloxacin / pharmacokinetics
probability
pmid:8517694
pmc187901
doi:10.1128/aac.37.5.1073
a forrest
d e nix
j j schentag
bacterial infections / drug therapy
critical illness
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.